KMID : 1138520160190020163
|
|
Journal of Pharmacopuncture 2016 Volume.19 No. 2 p.163 ~ p.166
|
|
Modulation of the Expression of the GABAA Receptor ¥â1 and ¥â3 Subunits by Pretreatment with Quercetin in the KA Model of Epilepsy in Mice
|
|
Moghbelinejad Sahar
Rashvand Zahra Khodabandehloo Fatemeh Mohammadi Ghazaleh Nassiri Asl Marjan
|
|
Abstract
|
|
|
Objectives: Quercetin is a flavonoid and an important dietary constituent of fruits and vegetables. In recent years, several pharmacological activities of quercetin, such as its neuroprotective activity and, more specifically, its anti-convulsant effects in animal models of epilepsy, have been reported. This study evaluated the role of quercetin pretreatment on gene expression of ¥ã-amino butyric acid type A (GABAA) receptor beta subunits in kainic acid (KA)-induced seizures in mice.
Methods: The animals were divided into four groups: one saline group, one group in which seizures were induced by using KA (10 mg/kg) without quercetin pretreatment and two groups pretreated with quercetin (50 and 100 mg/kg) prior to seizures being induced by using KA. Next, the messenger ribonucleic acid (mRNA) levels of the GABAA receptor ¥â subunits in the hippocampus of each animal were assessed at 2 hours and 7 days after KA administration. Quantitative real-time polymerase chain reaction (RT-PCR) assay was used to detect mRNA content in hippocampal tissues.
Results: Pretreatments with quercetin at doses of 50 and 100 mg/kg prevented significant increases in the mRNA levels of the ¥â1 and the ¥â3 subunits of the GABAA receptor at 2 hours after KA injection. Pretreatment with quercetin (100 mg/kg) significantly inhibited ¥â1 and ¥â3 gene expression in the hippocampus at 7 days after KA injection. But, this inhibitory effect of quercetin at 50 mg/kg on the mRNA levels of the ¥â3 subunit of the GABAA receptor was not observed at 7 days after KA administration.
Conclusion: These results suggest that quercetin (100 mg/kg) modulates the expression of the GABAA receptor ¥â1 and ¥â3 subunits in the KA model of epilepsy, most likely to prevent compensatory responses. This may be related to the narrow therapeutic dose range for the anticonvulsant activities of quercetin.
|
|
KEYWORD
|
|
beta subunits, GABAA, gene expression, kainic acid, quercetin
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|